Canada is set to begin receiving more than 2 million doses of the Pfizer-BioNTech vaccine each week as the two pharmaceutical firms ramp up their deliveries and begin shipping shots from the United States.
While SARS-CoV-2 infections continue to ravage many parts of the world, influenza (flu) cases in North America have hit a historic low. As winter approached last year, infectious disease experts warned of a “twindemic” in which the COVID-19 outbreak would combine with seasonal influenza to overwhelm the healthcare system.
Remdesivir is currently the only antiviral drug approved in the U.S. for treating COVID-19 patients.
On April 28, 2021, the Association for Molecular Pathology (AMP), Infectious Diseases Society of America (IDSA), and Pan American Society for Clinical Virology (PASCV) released a rapid communication concerning SARS-CoV-2 variant testing and sequencing in clinical settings.
Researchers at the National Institutes of Health have devised a four-part small-molecule cocktail that can protect stem cells called induced pluripotent stem cells (iPSCs) from stress and maintain normal stem cell structure and function
There are many different fields within the design/build industry, such as architecture, construction, engineering, and more.
Coronavirus vaccines have been developed and deployed in record time, but as global rollout has progressed, too few doses have been made available in low-income countries.
To help in the diagnosis and management of two sexually-transmitted diseases, another point-of-care diagnostic test will soon be available for use in physician’s offices, urgent care clinics, and other healthcare settings.
We need your help to grow this newsletter! Please pass along the subscription link to any colleague you think would benefit from hearing about med lab news.